E2 ModeratePreliminaryPEM unclearCross-SectionalPeer-reviewedMachine draft
Lower serum zinc in Chronic Fatigue Syndrome (CFS): relationships to immune dysfunctions and relevance for the oxidative stress status in CFS.
Maes, Michael, Mihaylova, Ivana, De Ruyter, Marcel · Journal of affective disorders · 2006 · DOI
Quick Summary
This study found that people with ME/CFS have lower levels of zinc in their blood compared to healthy people. The lower the zinc level, the worse some symptoms were, especially feelings of infection. Zinc helps protect the body from harmful molecules called free radicals, so low zinc may be one reason why ME/CFS involves increased stress and damage in the body.
Why It Matters
Low zinc status could be a treatable biomarker and potential therapeutic target in ME/CFS. This finding connects immune dysfunction and oxidative stress—two hallmark features of the disease—to a specific micronutrient that can be supplemented, offering a potential avenue for symptomatic or disease-modifying treatment.
Observed Findings
- Serum zinc concentrations are significantly lower in CFS patients than in healthy controls.
- Serum zinc levels show a negative correlation with CFS symptom severity.
- Serum zinc is significantly and negatively correlated with subjective experience of infection symptoms.
- Low serum zinc correlates with increased alpha2 protein fraction (inflammatory marker).
- Low serum zinc correlates with reduced T cell activation markers (CD69+ expression on CD3+ and CD3+CD8+ cells).
Inferred Conclusions
- CFS is accompanied by a low serum zinc status that is associated with signs of inflammation and defective T cell activation.
- The zinc deficiency in CFS supports the hypothesis that increased oxidative stress is a feature of the disease.
- Some CFS patients may benefit from antioxidant treatment, including zinc supplementation.
Remaining Questions
- Does zinc supplementation improve CFS symptoms or immune function in patients with low serum zinc?
- Is low zinc a primary feature of CFS or a secondary consequence of the disease process?
- What proportion of ME/CFS patients show zinc deficiency, and does it define a distinct patient subgroup?
What This Study Does Not Prove
This study does not prove that low zinc *causes* ME/CFS or that zinc supplementation will improve symptoms, as it only shows association, not causation. The cross-sectional design cannot determine whether zinc deficiency precedes CFS onset or develops as a consequence. Individual responses to zinc supplementation were not tested.
Tags
Symptom:Fatigue
Biomarker:CytokinesBlood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →